Joining the board of directors at Neurogen Corp. of Branford,Conn., are Mark Novitch, former vice chairman of the board atThe Upjohn Company, and Barry Bloom, former executive vicepresident of research and development at Pfizer Inc.
Corvas International Inc. of San Diego named to its board ofdirectors Blake Ingle, president and chief executive officer ofCanji Inc.
Paul Gargan has been appointed president of AmericanBiogenetic Science Inc. , replacing Kenneth Burk, who hasresigned for personal reasons. Gargan was senior vice presidentand director of research and development at the Notre Dame,Ind., company.
Amylin Inc. of San Diego has appointed Richard Kenley vicepresident of product development. Kenley was director ofpharmaceutical sciences at Genetics Institute Inc. Amylin alsopromoted Andrew Young to vice president of physiology fromsenior director of physiology and principal scientist, Mark Lotzto vice president of regulatory affairs and quality assurancefrom senior director, and Christopher Moyses to vice presidentof clinical and regulatory affairs, Europe, from senior director.
(c) 1997 American Health Consultants. All rights reserved.